|
Real-time Estimate
Tradegate
04:04:49 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 45.36 EUR | -0.10% |
|
-9.70% | +22.05% |
| 10-01 | Bayer Announces Alka-Seltzer Plus Relaunch As Alka-Seltzer Cold | CI |
| 10-01 | Frankfurt Stocks Close: Dax Below 25,000 Points, 200-Day Line Holds | DP |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50.22B | |||||
| 1,025B | |||||
| 623B | - | ||||
| 459B | |||||
| 355B | |||||
| 336B |
- Stock Market
- Stocks
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
